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reduce nonmedical prescription opioid use. 
Methods: Sixth graders from twenty-eight rural public school districts in Iowa and Pennsylvania were 
blocked by size and geographic location and then randomly assigned to experimental or control 
conditions. Within the intervention communities, prevention teams selected a universal family and 
school program from a menu of EBPIs. All families were offered a family-based program in the 6th 
grade and received one of three school-based programs in 7th-grade. The effectiveness and cost-
effectiveness of each school program by itself and with an additional family-based program was 
assessed using propensity and marginal structural models. 
Results: This work demonstrates that universal school-based EBPIs can efficiently reduce nonmedical 
prescription opioid use. Further, findings illustrate that family-based programs may be used to 
enhance the cost-effectiveness of school-based programs.  
Conclusions: Universal EBPIs can effectively and efficiently reduce nonmedical prescription opioid use 
should be further considered when developing comprehensive responses to this growing national 
crisis.  
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Abstract 
Purpose: Prescription drug abuse has reached epidemic proportions. Nonmedical prescription 
opioid use carries increasingly high costs. Despite the need to cultivate efforts that are both 
effective and fiscally responsible, the cost-effectiveness of universal evidence-based-preventive-
interventions (EBPIs) is rarely evaluated. This study explores the performance of these programs 
to reduce nonmedical prescription opioid use. 
Methods: Sixth graders from twenty-eight rural public school districts in Iowa and Pennsylvania 
were blocked by size and geographic location and then randomly assigned to experimental or 
control conditions (2002-2010). Within the intervention communities, prevention teams selected 
a universal family and school program from a menu of EBPIs. All families were offered a 
family-based program in the 6th grade and received one of three school-based programs in 7th-
grade. The effectiveness and cost-effectiveness of each school program by itself and with an 
additional family-based program was assessed using propensity and marginal structural models. 
Results: This work demonstrates that universal school-based EBPIs can efficiently reduce 
nonmedical prescription opioid use. Further, findings illustrate that family-based programs may 
be used to enhance the cost-effectiveness of school-based programs.  
Conclusions: Universal EBPIs can effectively and efficiently reduce nonmedical prescription 
opioid use should be further considered when developing comprehensive responses to this 
growing national crisis.
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Universal Prevention 1 
 
Can We Build an Efficient Response to the Prescription Drug Abuse Epidemic? 
Assessing the Cost-Effectiveness of Universal Prevention in the PROSPER Trial 
Prescription drug abuse has reached epidemic proportions in the United States with youth 
populations being especially vulnerable to abuse and addiction (CDC, 2011; Fischer et al., 2008; 
Havens, 2011; Hernandez and Nelson, 2010; Manchikanti and Singh, 2008; Maxwell, 2011; 
ONDCP, 2011;).  At the center of this growing crisis are prescription opioids, with over 12 
million Americans having used this pharmaceutical class for nonmedical purposes. Adolescent 
populations are particularly vulnerable to opioid misuse and abuse, with early initiation 
increasing the likelihood of future addiction (Compton and Volkow, 2006; McCabe, 2012, 2011, 
2009; Meier, 2012). In turn, these nonmedical user are estimated to cost society over $53 billion 
each year through their greater burden on health and service systems as well as increased rates of 
disability (Birnbaum et al., 2011; Coben et al., 2010; Hansen et al., 2011a; Johnston et al., 2010; 
SAMHSA, 2009).   
The rise in nonmedical prescription opioid use poses a major threat to public health and 
many policy makers are seeking to craft practical responses (ONDCP, 2011). Unfortunately, 
devising cost-effective initiatives that do not compromise pain management practices remains 
difficult (FDA, 2013; Fischer et al., 2008; Katz et al., 2007).  Despite development of approaches 
for reducing misusers’ access to prescription opioids (e.g., prescription-monitoring-systems, 
interdiction efforts), supply side methods are often resource intensive and may be difficult to 
effectively deploy during times of budgetary uncertainty. Instead policymakers may wish to 
engage more efficient solutions (Spoth, 2011a). For instance, demand reduction approaches that 
prevent nonmedical use, especially in at-risk populations, may offer a more fiscally responsible 
option (Catalano, 2009; Currie, 2005; O’Connell et al., 2009; Spoth, 2011b).  
One such approach is the use of universal school and family evidence-based-preventive-
interventions (EBPIs). Universal prevention programs1 target a whole population group (e.g., 
school) that has not been identified based upon individual risk (e.g., prenatal care, childhood 
immunization; (Greenberg et al., 2001).  For instance, universal school programs are offered to 
all students in a school and universal family programs can be offered to all families in 
community with no prior screening. These programs differ from other demand reduction 
                                                          
1 Not to be confused with universal precautions taken by prescribers to reduce the risk of misuse among patients 
(Gourlay and Heit, 2009) 
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approaches (e.g., public education and awareness campaigns) through their focus on reducing 
substance abuse risk (pro-abuse norms and expectations of use) and cultivating protective factors 
(refusal skills, social bonding, parental monitoring; (Hawkins et al., 1992; Kumpfer and 
Alvarado, 2003). Universal EBPIs are increasingly delivered within the context of formal 
prevention delivery and support systems that facilitate implementation and sustainability of 
prevention efforts (e.g., PROSPER, Weed & Seed, Communities-that-Care, SPF-SIG, Getting-to-
Outcomes; (Crowley et al., 2012; Hawkins, 1992, 2009; Spoth et al., 2004; Wandersman, 2000). 
Large demonstration trials, including the PROSPER study, have illustrated that EBPIs, delivered 
within these systems, represent a promising strategy for reducing nonmedical prescription opioid 
use (Aos et al., 2011, 2004; Guyll et al., 2011; Spoth et al., 2007a, Under Review; Spoth, 2006), 
but relatively little work has sought to evaluate these programs’ capacity to efficiently reduce 
nonmedical prescription opioid use in everyday contexts (Spoth et al., 2008). This lack of 
evaluation has contributed to universal EBPIs being largely overlooked and underutilized in 
recent federal and state responses.  
Limited work in this area has in part resulted from data limitations and methodological 
uncertainty around how to model the complex selection effects that lead to individuals receiving 
preventive interventions in school and family health service settings. In order to better 
understand the capacity of universal prevention efforts to reduce nonmedical prescription opioid 
use, we demonstrate a methodological approach to evaluate the cost-effectiveness of receiving 
multiple preventive interventions within different service settings. Specifically, through the use 
of propensity and marginal structural models we are able to first model who receives different 
programs when they are delivered in actual service contexts and then use these models to assess 
the incremental cost-effectiveness of programs. This differs from previous work that has 
assessed universal prevention largely within tightly controlled research trials that may 
overestimate intervention impact when programs are translated to non-research contexts.  We 
first evaluate the cost-effectiveness of three substance abuse school-based EBPIs to prevent 
nonmedical prescription opioid use (Life Skills Training, All Stars & Project Alert) delivered 
within the PROSPER delivery and support system. Next, the impact of a combined school and 
family-based programming approach is assessed for each of the three school programs with a 
family-based EBPI (SFP:10-14). This work builds on current understanding of universal 
prevention programs’ effectiveness and provides insight into their cost-effectiveness. Through 
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these analyses we gauge the real-world performance of universal programs in order to identify 
cost-effective approaches for reducing this growing epidemic. 
Methods 
In order to evaluate the cost-effectiveness of the four universal EBPIs in actual service 
settings, propensity and marginal structural models were fitted within a cost-effectiveness 
analysis of the PROSPER dissemination trial.  
Sample 
The National Institute of Health funded PROSPER dissemination trial included 14 
communities in Iowa and 14 communities in Pennsylvania based upon four criteria that included 
(1) school district enrollment between 1,301 and 5,200 students, (2) at least 15% of families 
eligible for reduced cost lunch, (3) maximum of 50% of the adult population employed at or 
attending a college or university, and (4) the community could not be involved in other 
university-affiliated, youth-focused prevention initiatives. Communities were matched by 
geographic location and size; each pair of communities was randomized into intervention and 
control conditions by the principal investigators (Spoth et al., 2007b, 2004). Approximately half 
the sample comprised the control condition (N=5,292; Figure 1). Within the intervention 
communities, local prevention teams led by local cooperative extension agents and school 
officials selected a universal family and school program from a menu of EBPIs (Spoth et al., 
2004). All families in intervention communities were offered the Strengthening Families 10-14 
program (SFP:10-14) in the 6th grade, but not all families enrolled (N=827). In addition, all youth 
in the intervention communities (N=5,026) received one of three school-based substance abuse 
programs in the 7th grade (All Stars (N=1,936), Life Skills Training (N=1,166) and Project Alert 
(N=1,924). Thus while the PROSPER participants were randomized to either intervention or 
control groups, the type of school intervention they received and whether they attended the 
family program was not randomized. Additional information about the different EBPIs may be 
found in Appendix 1. Program adherence was high for both school and family programs (M = 
90%; see (Spoth et al., 2011). The participating universities’ IRBs approved the study procedures 
before recruitment began. 
Measurement 
Estimates of Program Cost. The costs of the evidence-based prevention programs 
delivered within the PROSPER dissemination trial were estimated in an earlier prospective five-
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year cost analysis (Crowley et al., 2012). Opportunity costs were estimated from budgetary, 
sustainability, and volunteer-time data that tracked both expenditures from the parent grant and 
inputs from any outside sources. The cost to provide a school program to a single student was 
between $9-$27 and the average cost to provide the family program to a single family was 
between $311-$405. These costs included expenditures on curriculum and program supplies, 
facilitator time, family attendance incentives and volunteer/in-kind donation for programming. 
Nonmedical Prescription Opioid Use. To evaluate youth nonmedical prescription 
opioid use, each participant was asked whether they had ever used prescription opioids for 
nonmedical purposes at the 6th grade pre-test (2002-2010) and at the end of each year through 
12th grade [Have you ever used Vicodin®, Codeine, Percocet or OxyContin® not prescribed by a 
doctor?]. 
Analytic Approach 
As described above, PROPSER participants were randomized at the community level to 
treatment groups.  However, which school-based EBPI they received was chosen by each 
community’s team and families chose whether to attend the evening family program. Thus, in 
order to estimate the benefits of receiving the different school programs as well as the benefits of 
receiving the school and family programs together, a multi-step analytic framework was 
employed. This included (1) estimation of participants’ propensity to receive different programs, 
(2) fitting marginal structural models to estimate the impact of receiving different programs on 
ever using prescription opioids for non-medical purposes, (3) calculation of incremental cost-
effectiveness ratios, and (4) threshold analyses to assess whether a program represents an 
efficient societal investment.  
Propensity & Marginal Structural Models. Propensity and marginal structural models are 
well-established analytic tools used to improve causal inference when using observational data 
(Robins et al., 2000; Rosenbaum and Rubin, 1983). Propensity models were employed here to 
estimate the probability that an individual will receive each of the programs based upon a variety 
of prespecified covariates (See Appendix 1). Within this evaluation, we estimated individuals’ 
probabilities of receiving seven possible outcomes (i.e., participants’ propensity to receive either 
no program, one of the three school programs, or one of the three school programs and the 
family program). These probabilities were then transformed into inverse probability weights— 
which may be used similarly to survey weights—to balance the different possible forms of 
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treatment receipt on the confounders included in the propensity model. These weights were used 
to adjust marginal structural models, to estimate the effectiveness of the programs to reduce 
nonmedical prescription opioid use. PROC GLIMMIX was implemented to fit multi-level 
logistic models that accounted for the nested structure of the trial (i.e., participant nested within 
school, (Littell, 2006) Further description of the covariates that were included in the propensity 
models and how the propensity and marginal structural models were implemented may be 
accessed in Appendix 1 & 2. 
Incremental Cost-Effectiveness Analysis. Next, the incremental cost-effectiveness ratios 
(ICERs) for different levels of program receipt were estimated (Figure 1). The numerator of an 
ICER is the difference in costs for treatment outcomes (e.g., school program versus control). The 
denominator of the ICER is the difference in the average effect sizes of the two interventions. 
ICERs were calculated for each program combination that significantly reduced nonmedical use 
compared to the control condition (at the p ≤ .05 level). Statistical bootstrap techniques were 
employed to construct 95% confidence intervals around each ICER (using 1000 replications; 
(Briggs et al., 1997) 
Threshold Analysis. Each ICER was considered relative to the societal cost of allowing 
youth to engage in nonmedical prescription opioid use (i.e., Willingness-to-Pay). Recent 
analyses have placed the cost of nonmedical prescription opioid use at between $53.2 and $55.7 
billion annually. An estimated 12.5 million individuals reported using prescription opioids for 
non-medical purposes (Birnbaum et al., 2011; Hansen et al., 2011b). This translates into an 
approximate average societal cost of $4,132 per nonmedical opioid user per year. The average 
course of nonmedical use for this age group (late adolescence and early adulthood) is 2.17 years 
(Catalano et al., 2011). Based upon this previous work, it can be estimated that youth who 
engage in nonmedical prescription opioid use cost society approximately $8,966 per year. When 
discounted across the six years of program follow-up within the PROSPER trial, at a standard 
rate of 3%, this figure rounds to $7,500 (Russell et al., 1996). This estimate serves as the basis 
for a Willingness-to-Pay (WTP) threshold, where allocating less than $7,500 (i.e., the estimated 
societal cost of an adolescent or young adult nonmedical opioid user) to preventing a single case 
of nonmedical use is an economically efficient decision. In other words, if the 95% confidence 
interval of this ICER falls below this societal WTP, one could make a case that it is more 
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efficient to allocate the resources toward prevention services versus doing nothing and allowing 
the case of nonmedical opioid use to take its course.  
Results 
Here we consider the results of the effectiveness, cost-effectiveness, and threshold 
analyses in order to ascertain the impact and efficiency of the three school programs with and 
without the family program compared to those youth in the control group.  As presented in Table 
1, there is increasing lifetime use of prescription opioids across adolescence with over 25% of 
seniors ever having used a prescription opioid that was not prescribed by a doctor. 
Effectiveness Analyses. The effectiveness of the different PROSPER program 
combinations were evaluated to assess the impact of the school and family program, compared to 
the control condition (Table 2; incremental effect). Receipt of the Life Skills Training Program 
led to a significantly reduced probability of youth having ever used prescription opioids for 
nonmedical purposes by grade 12 compared to the control condition (Control v. Life Skills 
Alone: 3.9%-4.9% reduction). No significant differences were observed between the All Stars 
and Project Alert Programs compared to the control condition. Receipt of the Life Skills and 
SFP:10-14 programs together as well as receipt of the All Stars and SFP:10-14 programs 
together revealed a significant difference from the control condition (Control v. Life Skills & 
SFP:10-14 Combined: 5.8%-10.5% reduction; Control v. All Stars & SFP:10-14 Combined; 
6.8%-8.5% reduction). Life Skills Training in conjunction with SFP:10-14 was the most 
effective in reducing nonmedical prescription opioid use (Figure 2).  
Cost-Effectiveness Analysis. Table 2 provides ICERs (i.e., the difference of the average 
of the predicted probabilities for the treatment and comparison groups) and their standard errors. 
The Life Skills Training program alone compared to the control group had the lowest ICER and 
thus is the program option with the greatest relative productive efficiency (ICER = $613). One 
may interpret this as a $613 cost (95% CI: $548-693) to prevent one youth from misusing 
prescription opioids before 12th grade who would otherwise have engaged in nonmedical use if 
they had not received the program.  
Threshold Analysis. The Life Skills Training program was the only school program that 
when delivered alone significantly reduced nonmedical use compared to the control group. Thus, 
the Life Skills Training program alone would be considered a cost-effective approach for 
reducing nonmedical prescription opioid use. Further, when compared to the control group, 
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individuals who received SFP:10-14 as well as either All Stars or Life Skills Training were both 
below the WTP threshold.  Thus both Life Skills and All Stars when delivered with SFP:10-14 
significantly reduce nonmedical use and would be cost-effective allocation of societal resources. 
When compared to each other, where the Life Skills and SFP:10-14 combination has a lower 
ICER than the All Stars and SFP:10-14 combination, we can infer that the most efficient 
allocation of societal money would be to invest in the combined delivery of the Life Skills and 
SFP:10-14 programs. 
Discussion 
 Policy-makers and community leaders are actively searching for efficient responses to the 
growing prescription drug epidemic (FDA, 2013; Maxwell, 2011; ONDCP, 2011). In particular, 
due to prescription opioids’ growing popularity among adolescents and young adults, it is vital 
that any coordinated strategy meets the needs of this vulnerable population. Without an effective 
approach for curbing nonmedical use, Federal agencies are being forced to restrict access to 
prescription opioids –at the cost of greater burden on suffering patients (Volkow, 2011). The 
present study builds on earlier reports universal EBPIs implemented effectiveness and 
demonstrates that universal school-based EBPIs are capable of reducing nonmedical prescription 
opioid use by youth in a cost-effective manner and may supplement costly approaches to monitor 
and restrict access (Spoth et al., 2008; Spoth et al., 2008). Further, this evaluation reveals the 
potential of family-based EBPIs during early adolescence to enhance the efficiency of school-
based programs. Thus, by employing propensity and marginal structural models we are able to 
leverage the unique data within the PROSPER trial to compare the impact of the different school 
programs and family programs. 
 In light of these findings, decision makers seeking to craft comprehensive responses to 
prescription drug abuse may wish to consider the potential value of broader evidence-based drug 
use prevention efforts that nurture healthy cognitions and behaviors by parents and youth. In 
particular, current estimates illustrate that nonmedical use is continuing to rise despite early 
efforts to stem the tide of abuse and now may be time to engage new options (ONDCP, 2011). 
This approach may reduce demand for tertiary approaches which while cost-effective may garner 
less public support (e.g., soboxone and methadone maintenance; Polsky et al., 2010).   
By employing the analytic approach described above we can better understand universal 
prevention’s cost-effectiveness, and these specific analyses reveal the value of intervening across 
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ecological settings when targeting youth populations. Specifically, programs operating in school 
and family settings may be crucial to successful efforts. These results also emphasize that, like 
medical treatments, not all evidence-based programs are equivalent and that interventions that 
have met accepted standards of evidence (e.g., Blueprints) may not be cost-effective. Lastly, this 
work illustrates that different elements of a multifaceted response are not simply additive and 
may in fact interact in important ways. For instance, when the Life Skills Training and All Stars 
programs are delivered with the SFP:10-14 program their performance is enhanced. This is not 
true for the Project Alert program, which was not significantly better or worse at preventing 
nonmedical use when delivered with the SFP:10-14 program. Such unique interactions may also 
extend to efforts that combine prevention with medical treatment, interdiction and enforcement. 
This evaluation sought to understand the cost-effectiveness of universal EBPIs 
specifically on preventing prescription opioid abuse. This is likely a dramatic underestimate of 
the total societal value from universal programs that are known to not only prevent other forms 
of substance abuse (e.g., alcohol, tobacco, methamphetamines; Guyll et al., 2011; Spoth et al., 
2008b) but a variety of delinquent behaviors linked to long-term criminality and increased use of 
social service systems (Aos et al., 2011). Nevertheless, compared to approaches that aim to 
reduce nonmedical use that is already occurring (e.g., treatment), a prevention-oriented approach 
to nonmedical use may be especially well-suited for society’s current needs. For instance, opioid 
addiction is generally considered a chronic illness and requires costly treatments that quickly 
overburden community service systems (McLellan, 2000). Consequently, even small reductions 
in those ever requiring treatment can save substantial public monies. Alternately, because of the 
important role of prescription opioids in pain management, interdiction and enforcement efforts 
may harm or stigmatize those with legitimate medical need. Universal prevention efforts that 
serve entire populations, targeting risk and protective factors for nonmedical use, can offer 
society a means of protecting youth populations from nonmedical use while allowing those who 
are suffering access to the best possible therapies. 
Limitations 
 A substantial body of literature has illustrated that—across settings—adequate capacity is 
essential for high-quality implementation of evidence-based programs and practices (e.g., 
hospital, school, clinical). It is increasingly advised that large-scale delivery of such efforts not 
be attempted without formal capacity building (Samet, 2001; Spoth et al., 2004; Wandersman, 
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2000). In particular, delivery of universal EBPIs without such support can lead to diminished 
impact and lower levels of program efficiency (Spoth et al., 2004). In response, substance abuse 
researchers working with youth populations have developed multiple support systems that can 
effectively cultivate and maintain such capacity (Dunworth et al., 1999; Hawkins, 1992; Spoth et 
al., 2004). To maximize the generalizability of these estimates, this study considers program 
impact when delivered within such a system (i.e., PROSPER; (Spoth et al., 2004). Thus these 
estimates are not applicable to attempts to deliver universal EBPIs without such support systems 
as both the costs and effectiveness are likely to differ. 
 A second limitation of this work pertains to the Willingness-to-Pay threshold based on 
recent cost-of-illness estimates of prescription opioid nonmedical use. These estimates consider 
the health and productivity outcomes of individuals misusing prescription opioids, but fail to 
capture many growing downstream costs (e.g., malpractice litigation, interdiction efforts). 
Additionally, as little contingent valuation work has sought to estimate Quality Adjusted Life 
Years (QALYs) for opioid misuse and none have estimated QALYs of nonmedical prescription 
opioid use within youth populations (Connock et al., 2007; Schackman et al., 2012).  
Consequently, these estimates most likely undervalue the total societal costs of nonmedical 
prescription opioid use. This in turn may have resulted in an overly conservative Willingness-to-
Pay threshold. This lower threshold is unlikely to have influenced the inferences drawn from this 
study, as all programming options that significantly reduced nonmedical use were represented by 
ICERs well below the threshold. Thus this threshold should be updated as revised cost-of-illness 
estimates become available. 
 Lastly, it is possible that the control communities also had access to the programs 
implemented by the intervention communities. This may have led to potentially lower program 
effectiveness then observed within this evaluation and thus estimates of cost-effectiveness are 
likely conservative.  Further research is needed to explore the cost-effectiveness of combining 
other substance abuse prevention programs, including those outside family and school settings. 
Conclusion 
 With this work we seek to draw attention to the potential value of universal school- and 
family-based EBPIs as part of an efficient response to the growing prescription drug epidemic. 
Given the rapid changes in health care policy and the opportunities provided for prevention and 
health promotion services in The Affordable Care Act,  the use of community-based prevention 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
Universal Prevention 10 
 
services will expand and the evidence here indicates that if effective programs are used it can 
significantly reduce public and private cost (Koh and Sebelius, 2010). It is vital that future 
research evaluate the effectiveness and cost-effectiveness of these programs and policies in 
various US communities in order to truly craft the most efficient response.
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Appendix 1: The PROSPER System and EBPIs Included in Trial 
 
The PROSPER delivery and support system links stakeholders from the state and local 
cooperative extension service (CES) and local public school systems for the purpose of 
implementing school- and family-based preventive interventions (Spoth et al., 2004). An 
embedded CES agent and a school official comprise the core of community prevention teams 
that involve multiple members representing various community interests. The local teams are 
supported by prevention coordinators in the CES and by university prevention teams (for a 
review, see Spoth et al., 2004). The teams each select from a menu of school and family 
evidence-based programs and offer those programs to youth and families within the community. 
Within the PROSPER dissemination trial three school programs were delivered (each 
community only delivers one of these programs): Life Skills Training, Project Alert and All 
Stars. Additionally, all PROSPER communities chose to deliver the Strengthening Families 
Program: For Parents and Youth Ages 10-14. 
Project Alert. Project Alert is a school-based program that attempts to reduce substance 
use by targeting negative social influences that encourage use and promote social norms that 
reduce the likelihood of substance use. The program is comprised of 11 sessions that involve 
interactive activities such as role-playing, skills rehearsal and small group activities.  
All Stars. All Stars is a school based program consisting of 13 sessions that seeks to 
promote healthy beliefs regarding drug use, create conventional norms against substance use, 
build strong personal commitments, facilitate school bonding, and increase parental monitoring. 
Activities are interactive, consisting of games, art activities, and small group discussions.44–46 
Life Skills Training. Life Skills Training is a school based program that aims to prevent 
substance use and abuse by changing social influence and competencies. In particular, this 
program seeks to teach social skills that build personal competence as well as facilitate 
assertiveness and refusal of substances across 18 sessions.37,47,48 
The Strengthening Families Program (SFP:10-14) 10-14. SFP:10-14 is a family-based 
program designed to reduce substance use and is grounded in a variety of family, resilience and 
biopsychosocial etiological theories. Families receive seven sessions (one per week) with parents 
and youth separated for an hour and then together (for an additional hour). The program seeks to 
reduce risk factors such as poor parental monitoring and bonding as well as issues of socio-
emotional health. 
Table 1: Baseline Demographic Characteristics 
 Intervention Control 
Age 11.85 (.43) 11.82 (.42) 
Gender (Male) 50.0% 49.2% 
Dual Parent Family 50.2% 52.7% 
Income $50,174 (32,994) $52,704 (42,762) 
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Appendix 2: Statistical Methods 
In order to estimate the benefits of receiving the different programs delivered within 
PROSPER as well as the benefits of receiving multiple programs, a five- step analytic 
framework is employed (see Coffman et al., 2011). These steps include (1) defining the causal 
effects, (2) estimation of participant propensity to receive different program levels, (3) 
calculation and application of inverse probability weights to account for selection effects, (4) 
evaluation of the balance between program levels, and (5) outcome analyses of the impact of 
different program levels on ever using prescription opioids for nonmedical purposes.  
Overall missingness was low and participation was similar to comparable longitudinal 
trials. The average missingness of an item was about 10.0% (SD=9.7%). Previous evaluations of 
PROSPER explored the study’s missingness and found no evidence of threats to internal validity 
from differential sample attrition at grade 12. Multiple imputation was used to account for any 
missing data (STATA MI mvn)50–52 This procedure uses an iterative Markov chain Monte Carlo 
(MCMC) method to impute missing values using a joint modeling approach under a multivariate 
normal model. The mvn approach uses estimates from the EM algorithm as starting values for 
the MCMC procedure. Twenty imputations were obtained and each imputation was drawn after a 
burn-in period of 100 iterations. The mvn procedure applied to handle missing data allowed for 
complete data analysis for both the propensity models and the outcome analysis. 
Defining Casual Effects. The causal effects are defined using marginal structural models, 
which are models for potential outcomes.53 Let s denote the school program, but now rather than 
s = 1 or 0, s takes on the following values:  s = 0 if the youth did not receive any school program, 
s = 1 if the youth received Life Skills, s = 2 if the youth received All Stars, s = 3 if the youth 
received Project Alert. As before, f denotes the family program and equals 1 if the youth received 
SFP:10-14 and 0 otherwise. Thus, the potential outcomes are Y(0,0) if the youth did not receive 
any of the three school programs or the family program, Y(1,0) if the youth received Life Skills 
Training and did not receive the SFP:10-14, Y(1,1) if youth received Life Skills Training and 
SFP:10-14, Y(2,0) if youth received All Stars and did not receive SFP:10-14, Y(2,1) if the youth 
received All Stars and SFP:10-14, Y(3,0) if youth received Project Alert and did not receive 
SFP:10-14, Y(3,1) if the youth received Project Alert and SFP:10-14. Note that again there is a 
monotonic function in that if a youth does not receive the school program they cannot receive the 
family program. Thus the potential outcome Y(0,1) does not exist. The causal effects are the 
effect of receiving in Life Skills Training versus not receiving the school 
program ,  the effect of receiving the Life Skills Training and receiving the 
SFP:10-14 versus not receiving either program , the effect of receiving the 
Life Skills Training and SFP:10-14 versus receiving only the school 
program  (Research Question Grouping 4), the effect of receiving the All 
Stars versus not receiving the school program , the effect of receiving All 
Stars and receiving SFP:10-14 versus not receiving either program , the 
effect of receiving All Stars and SFP:10-14 versus receiving only the school 
program  (Research Question Grouping 5), (6) the effect of receiving Project 
Alert versus not receiving the school program , the effect of receiving 
Project Alert and receiving SFP:10-14 versus not receiving either program  , 
the effect of receiving Project Alert and SFP:10-14 versus receiving only the school 
program  (Research Question Grouping 6).The marginal structural model for 
the potential outcomes is given as: 
 
Where l, a, and p are dummy variables and l = 1 if the youth received Life Skills and 0 
otherwise, a = 1 if the youth received All Stars and 0 otherwise, and p =1 1 if the youth received 
Project Alert and 0 otherwise. Thus, the causal effect given in Equations 4-12 are equal to: 
4.  
5.  
6.  
7.  
8.  
9.  
10.  
11.  
12.  
Becuase marginal structural models are models for the potential outcomes and not all the 
potential outcomes are observed, they cannot be estimated without further assumptions. 
Specifically, to estimate these models the assumption is made that there are no unaccounted for 
confounders influencing receipt of either the school or family programs, and thus, the causal 
effects are estimated using inverse probability weighted models for the observed outcomes. 
Propensity Score Estimation Process. Within this project, two sets of propensity scores 
are estimated. Using multinomial logistic models, the propensity a person receives— (1) no 
program, (2) the school program, and (3) the school and family program together, is estimated 
using a multinomial logistic regression. Because communities voluntarily picked one of the three 
offered school programs, a second set of propensity scores is then estimated for receipt of the 
different school-based programs also using a multinomial regression.54 Both of these analyses 
were carried out using the GLIMMIX procedure in SAS 9.131 that allows for specification of a 
link function, which for multinomial logistic and count data estimated here is log. This procedure 
also estimates error terms for non-normally distributed dependent variables. The propensity 
models to estimate these scores employ confounders across participant, organizational, 
infrastructure and community levels to predict program receipt and meet the stable unit treatment 
value assumption (SUTVA; described above). In order to test whether the logit link was 
appropriate, the Hinkley test was employed.55 This test includes the logit propensity score 
squared as a covariate in the propensity model to test whether it is significantly related to the 
treatment condition in the presence of the other confounders. 
In this study, propensity models were estimated for both the probability of participants 
being in the different school programs and the family program. Both models passed the 
Hinkley’s test described above and were found to have suitable overlap.55 Inverse probability 
weights were calculated and further diagnostics of balance were conducted. Unweighted and 
weighted standardized mean differences (SMD) between the control and treatment groups were 
calculated for each confounder in both propensity models.30 Weighting generally lowered or 
maintained the SMDs of each confounder and no confounders had an absolute SMD above .2 
when weighted, which is generally considered to be small.56 Finding a small effect size across 
the confounders included in the model indicates that the different treatment groups are balanced 
and increases confidence in causal inferences. 
Inverse Probability of Treatment Weight Calculation. Next the inverse probability 
weights for the combination of school program (IPWs) and family programming (IPWf) actually 
received by each participant are calculated. The IPWs are similar to survey weights and allow us 
to make adjustments to the sample data to account for selection effects affecting both school and 
family program receipt by up-weighting those who are underrepresented and down weighting 
those who are over represented.57 When modeling multiple variables—such as the two types of 
program receipt considered here—the product of the variables’ weights is used.29 
Let t  be the estimated propensity to not receive the family program and  be the 
estimated propensity to receive the family program. For youth who receive the family program, 
wtf  =  and for youth who do not receive it, wtf  = . Let  be the estimated propensity of 
receiving Life Skills Training,  the estimated propensity of receiving All Stars, and  the 
estimated propensity of receiving Project Alert. For youth who receive Life Skills, wtl  = . For 
youth who receive All Stars, wta = . For youth who receive Project Alert, wtp = . The 
product, wts*wtf is the weight used. 
Balance Evaluation. Next the balance of the different groups is evaluated before and after 
weighting to ascertain whether the adjustment using the IPWs successfully balanced the different 
groups. Balance was evaluated using standardized mean differences. Group overlap was also 
evaluated by examining boxplots of the distributions of the logit propensities by school and 
family program.  
Outcome Analysis. The fifth step evaluates how receiving different amounts of 
programming impacts participant outcomes using the IPWs. In this case, prescription opioid 
misuse is evaluated in terms of receipt of the school and family program as well as by each 
school program. To evaluate the effect of differential program receipt, I constructed two logistic 
models to examine differences between program receipt using the IPW estimation method. 
MS Model 1:  
For Model 1, β1 is the effect of receiving either no programs vs. the school program, and β2 is the 
effect of receiving the family program in addition to the school program. For model 2, β1 is the 
effect of receiving Life Skills Training vs. not, β2 is the effect of receiving All Stars vs. not, β3 is 
the effect of receiving Project Alert vs. not, β4 is the effect of receiving SFP:10-14 in addition to 
Life Skills, β5 is the effect of receiving SFP:10-14 in addition to All Stars, and β6 is the effect of 
receiving SFP:10-14 in addition to Project Alert. Thus the IPWs are employed to meet the 
assumption that no confounders are unaccounted for in the outcome analysis; these β’s , which 
correspond to those in the marginal structural models, can be interpreted as causal effects. 
The outcome model, which is fit using the PROC GLIMMIX procedure, includes a 
binary outcome measure of whether youth had ever misused prescription opioids. PROC 
GLIMMIX allows a weighting function that may be employed to include the IPWs in the model 
and provides robust standard errors. This procedure allows for the inclusion of the two-level 
nested design of the model, with individuals nested within communities.31 
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